Dudediligence.

Synergy CHC Corp

SNYRNASDAQ · Medicinal Chemicals & Botanical Products
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

11.3M

on 2026-03-31, from 7.55M on 2024-09-30 10-Q ↗

a raise that quarter, at its price

5M10MSep2024DecMar2025JunSep$2.50DecMar2026

Newest

$100.0M

S-3 of 2025-11-26. 1 prospectus supplement filed under it since. S-3 ↗

$5.7M

Roth Capital Partners, agreement of 2025-12-09. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-05-14 is not read yet.

Cash

0.3 quarters

$292K on 2026-03-31 ÷ $952K a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-08-25Public offeringnot read$2.50$4.4M424B4 ↗